The Purpose of This Study is to Determine The Efficacy and Safety of a Systemic Hedgehog Pathway Antagonist (GDC-0449) in Patients With Basal Cell Nevus Syndrome (BCNS)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Genentech
Information provided by (Responsible Party):
Rajnesh Prasad, MBA, Children's Hospital & Research Center Oakland
ClinicalTrials.gov Identifier:
NCT00957229
First received: August 5, 2009
Last updated: February 19, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2015
  Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
No publications provided by Children's Hospital & Research Center Oakland

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):